WO2008149803A1 - Procédé de tri et d'identification de cellules souches cancéreuses dans une leucémie lymphocytaire aiguë à l'aide de marqueurs d'antigène de surface - Google Patents

Procédé de tri et d'identification de cellules souches cancéreuses dans une leucémie lymphocytaire aiguë à l'aide de marqueurs d'antigène de surface Download PDF

Info

Publication number
WO2008149803A1
WO2008149803A1 PCT/JP2008/060012 JP2008060012W WO2008149803A1 WO 2008149803 A1 WO2008149803 A1 WO 2008149803A1 JP 2008060012 W JP2008060012 W JP 2008060012W WO 2008149803 A1 WO2008149803 A1 WO 2008149803A1
Authority
WO
WIPO (PCT)
Prior art keywords
stem cells
lymphocytic leukemia
cancer stem
acute lymphocytic
surface antigen
Prior art date
Application number
PCT/JP2008/060012
Other languages
English (en)
Japanese (ja)
Inventor
Chikao Morimoto
Hiroto Yamazaki
Hiroko Nishida
Original Assignee
The University Of Tokyo
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by The University Of Tokyo filed Critical The University Of Tokyo
Publication of WO2008149803A1 publication Critical patent/WO2008149803A1/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0693—Tumour cells; Cancer cells
    • C12N5/0695—Stem cells; Progenitor cells; Precursor cells
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57407—Specifically defined cancers
    • G01N33/57426—Specifically defined cancers leukemia
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/705—Assays involving receptors, cell surface antigens or cell surface determinants
    • G01N2333/70596—Molecules with a "CD"-designation not provided for elsewhere in G01N2333/705

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Hematology (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cell Biology (AREA)
  • Urology & Nephrology (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Oncology (AREA)
  • Genetics & Genomics (AREA)
  • Hospice & Palliative Care (AREA)
  • Developmental Biology & Embryology (AREA)
  • General Engineering & Computer Science (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

En découvrant des marqueurs d'antigène de surface qui sont positifs spécifiquement à des cellules souches cancéreuses dans une leucémie lymphocytaire aiguë, on vise à proposer un nouveau procédé pour trier et identifier des cellules souches cancéreuses dans une leucémie lymphocytaire aiguë avec l'aide des marqueurs ci-dessus et un coffret pour ceux-ci. A l'aide des marqueurs d'antigène de surface CD90 et CD110 comme indications, des cellules souches cancéreuses dans une leucémie lymphocytaire aiguë de lymphocytes T (TOUT-T) sont triées. A l'aide des marqueurs d'antigène de surface CD9 ou CD9 avec CD90 en tant qu'indications, des cellules souches cancéreuses dans une leucémie lymphocytaire aiguë de lymphocytes B (TOUT-B) sont triées.
PCT/JP2008/060012 2007-06-06 2008-05-30 Procédé de tri et d'identification de cellules souches cancéreuses dans une leucémie lymphocytaire aiguë à l'aide de marqueurs d'antigène de surface WO2008149803A1 (fr)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
JP2007-150912 2007-06-06
JP2007150912 2007-06-06
JP2007-159355 2007-06-15
JP2007159355 2007-06-15

Publications (1)

Publication Number Publication Date
WO2008149803A1 true WO2008149803A1 (fr) 2008-12-11

Family

ID=40093621

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/JP2008/060012 WO2008149803A1 (fr) 2007-06-06 2008-05-30 Procédé de tri et d'identification de cellules souches cancéreuses dans une leucémie lymphocytaire aiguë à l'aide de marqueurs d'antigène de surface

Country Status (1)

Country Link
WO (1) WO2008149803A1 (fr)

Cited By (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2012031280A3 (fr) * 2010-09-03 2012-07-12 Stem Centrx, Inc. Identification et enrichissement de sous-populations cellulaires
JP2012522217A (ja) * 2009-03-24 2012-09-20 バイオセプト インコーポレイティッド 細胞の捕捉および解析のデバイスおよび方法
CN103547597A (zh) * 2011-02-18 2014-01-29 施特姆森特Rx股份有限公司 新型调节剂及使用方法
US9534058B2 (en) 2012-02-08 2017-01-03 Abbvie Stemcentrx Llc Anti-CD324 monoclonal antibodies and uses thereof
US9671407B2 (en) 2009-03-24 2017-06-06 Biocept, Inc. Devices and methods of cell capture and analysis
US9777070B2 (en) 2014-04-30 2017-10-03 Pfizer Inc Anti-PTK7 antibody-drug conjugates
US9778264B2 (en) 2010-09-03 2017-10-03 Abbvie Stemcentrx Llc Identification and enrichment of cell subpopulations
US10018630B2 (en) 2011-09-07 2018-07-10 Chugai Seiyaku Kabushiki Kaisha Cancer stem cell isolation
US10934351B2 (en) 2011-10-28 2021-03-02 Chugai Seiyaku Kabushiki Kaisha Cancer stem cell-specific molecule
US11124773B2 (en) 2010-10-06 2021-09-21 Chugai Seiyaku Kabushiki Kaisha Cancer stem cell population and method for production thereof
US11536713B2 (en) 2009-12-25 2022-12-27 Chugai Seiyaku Kabushiki Kaisha Method for searching and screening for target of anti-cancer agent using non-human animal model having NOG established cancer cell line transplanted therein

Non-Patent Citations (10)

* Cited by examiner, † Cited by third party
Title
FICKERT S. ET AL.: "Identification of subpopulations with characteristics of mesenchymal progenitor cells from human osteoarthritic cartilage using triple staining for cell surface markers", ARTHRITIS RES. THER., vol. 6, no. 5, 2004, pages R422 - R432, XP021011511 *
INABA T. ET AL.: "Flow cytometric analysis of Thy-1 expression in myelodysplastic syndrome", INT. J. HEMATOL., vol. 68, no. 4, 1998, pages 403 - 410 *
IRIMAJIRI K.: "Hakketsubyo to Rinsho Kensa 2 Kyusei Lymph-sei Hakketsubyo (2)", MEDICAL TECHNOLOGY, vol. 16, no. 5, 1988, pages 391 - 397 *
NISHIDA H.: "B Saibo Lymph-kei Zoketsuki Shuyo ni Okeru Gan Kansaibo no Dotei to Kaiseki", RINSHO KETSUEKI, vol. 48, no. 9, 30 September 2007 (2007-09-30), pages 874 + ABSTR. NO. OS-18-5 *
RAMZI M.M. ET AL.: "Bryostatin 1 induces ubiquitin COOH-terminal hydrolase in acute lymphoblastic leukemia cells", ENZYME PROTEIN, vol. 49, 1996, pages 262 - 272, XP002916202 *
UCKUN F.M. ET AL.: "Use of a novel colony assay to evaluate the cytotoxicity of an immunotoxin containing pokeweed antiviral protein against blast progenitor cells freshly obtained from patients with common B-lineage acute lymphoblastic leukemia", J. EXP. MED., vol. 163, no. 2, 1986, pages 347 - 368, XP000611309 *
XAVIER THOMAS ET AL.: "CD34 expression is associated with major adverse prognostic factors in adult acute lymphoblastic leukemia", LEUKEMIA, vol. 9, no. 2, 1995, pages 249 - 253 *
YAMAZAKI H.: "Hito Kyusei Lymph-sei Hakketsubyo ni Okeru Gan Kansaibo no Dotei", REGENERATIVE MEDICINE, vol. 7, 22 February 2008 (2008-02-22), pages 232 + ABSTR. NO. O-32-3 *
YAMAZAKI H.: "Isolation of cancer stem cells in human T-cell acute lymphoblastic leukemia cell lines", DAI 66 KAI NIHON GAN GAKKAI GAKUJUTSU SOKAI KIJI, vol. 66TH, 25 August 2007 (2007-08-25), pages 52 *
ZHANG S.-L. ET AL.: "Analysis of surface antigen on lymphoid malignancies in children", JAPANESE JOURNAL OF PEDIATRIC HEMATOLOGY, vol. 4, no. 5, 1990, pages 457 - 462 *

Cited By (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10527611B2 (en) 2009-03-24 2020-01-07 Biocept, Inc. Devices and methods of cell capture and analysis
JP2012522217A (ja) * 2009-03-24 2012-09-20 バイオセプト インコーポレイティッド 細胞の捕捉および解析のデバイスおよび方法
US9128082B2 (en) 2009-03-24 2015-09-08 Biocept, Inc. Devices and methods of cell capture and analysis
US11719692B2 (en) 2009-03-24 2023-08-08 Biocept, Inc. Devices and methods of cell capture and analysis
US9671407B2 (en) 2009-03-24 2017-06-06 Biocept, Inc. Devices and methods of cell capture and analysis
US11536713B2 (en) 2009-12-25 2022-12-27 Chugai Seiyaku Kabushiki Kaisha Method for searching and screening for target of anti-cancer agent using non-human animal model having NOG established cancer cell line transplanted therein
US9778264B2 (en) 2010-09-03 2017-10-03 Abbvie Stemcentrx Llc Identification and enrichment of cell subpopulations
AU2016201730B2 (en) * 2010-09-03 2018-01-25 Abbvie Stemcentrx Llc Identification and enrichment of cell subpopulations
WO2012031280A3 (fr) * 2010-09-03 2012-07-12 Stem Centrx, Inc. Identification et enrichissement de sous-populations cellulaires
US9945842B2 (en) 2010-09-03 2018-04-17 Abbvie Stemcentrx Llc Identification and enrichment of cell subpopulations
US11965180B2 (en) 2010-10-06 2024-04-23 Chugai Seiyaku Kabushiki Kaisha Cancer stem cell population and method for production thereof
US11124773B2 (en) 2010-10-06 2021-09-21 Chugai Seiyaku Kabushiki Kaisha Cancer stem cell population and method for production thereof
US10836831B2 (en) 2011-02-18 2020-11-17 Abbvie Stemcentrx Llc Anti-PTK7 antibodies and methods of use
US9914784B2 (en) 2011-02-18 2018-03-13 Abbvie Stemcentrx Llc PTK7 modulators and methods of use
US9409995B2 (en) 2011-02-18 2016-08-09 Stemcentrx, Inc. PTK7 modulators and methods of use
CN103547597A (zh) * 2011-02-18 2014-01-29 施特姆森特Rx股份有限公司 新型调节剂及使用方法
US10018630B2 (en) 2011-09-07 2018-07-10 Chugai Seiyaku Kabushiki Kaisha Cancer stem cell isolation
US10934351B2 (en) 2011-10-28 2021-03-02 Chugai Seiyaku Kabushiki Kaisha Cancer stem cell-specific molecule
US11858987B2 (en) 2011-10-28 2024-01-02 Chugai Seiyaku Kabushiki Kaisha Cancer stem cell-specific molecule
US10087258B2 (en) 2012-02-08 2018-10-02 Abbvie Stemcentrx Llc Anti-CD324 monoclonal antibodies and uses thereof
US9534058B2 (en) 2012-02-08 2017-01-03 Abbvie Stemcentrx Llc Anti-CD324 monoclonal antibodies and uses thereof
US9777070B2 (en) 2014-04-30 2017-10-03 Pfizer Inc Anti-PTK7 antibody-drug conjugates

Similar Documents

Publication Publication Date Title
WO2008149803A1 (fr) Procédé de tri et d'identification de cellules souches cancéreuses dans une leucémie lymphocytaire aiguë à l'aide de marqueurs d'antigène de surface
WO2006089091A3 (fr) Procedes pour la detection de maladie residuelle minimale
WO2007079183A3 (fr) Populations de cellules souches placentaires
WO2005021728A3 (fr) Populations de cellules progenitrices et de cellules souches pancreatiques enrichies, methodes d'identification, d'isolement et d'enrichissement de ces populations
EP4249605A3 (fr) Procédés de détection d'analyte
WO2012009644A3 (fr) Procédés pour identifier des éléments d'arn synthétiques et naturels qui améliorent la traduction des protéines
WO2006105152A3 (fr) Compositions a base de cellules amniotiques, methodes de production et utilisations desdites compositions
WO2012021795A3 (fr) Biomarqueurs du cancer du pancréas et leurs utilisations
NO20075379L (no) Fremgangsmate ved vedlikehold av en bronn med bronnvaeske omfattende et elastisk materiale.
WO2010033906A3 (fr) Induction efficace de cellules souches pluripotentes au moyen de composés à petite molécule
WO2008002712A3 (fr) Systèmes et procédés d'intégration de sous-traitance
WO2008118392A3 (fr) Plate-formes synthétiques de cellules et leurs procédés d'utilisation
GB2449772A (en) Large scale production of stem cells
WO2009129505A3 (fr) Compositions, procédé et trousses utilisant des sondes synthétiques pour déterminer la présence d'un acide nucléique voulu
WO2009114185A3 (fr) Procédés et compositions pour profil translationnel et phénotypage moléculaire
GB0600916D0 (en) detecting and predicting pre-eclampsia
WO2008124559A3 (fr) Revêtements transparents durables pour des substrats polymères
WO2008095905A3 (fr) Liaison d'agents pathogènes
WO2006107670A3 (fr) Etudes d'association in vitro
DE502007004748D1 (de) Werkzeughalter, insbesondere für ein stechwerkzeug sowie schneidkörper für einen werkzeughalter
WO2008034622A3 (fr) Méthode de détection et/ou de quantification de l'expression d'une protéine cible candidate dans une cellule et méthode d'identification d'une protéine cible d'un modulateur de molécules de petite taille
WO2006129036A3 (fr) Biomarqueur a emission luminescente
WO2007127659A3 (fr) Méthodes et compositions pour la séparation de cellules
WO2011059189A3 (fr) Méthode d'identification de cellules souches mésenchymateuses par emploi d'un anticorps anti-tm4sf1 et composition
WO2012135635A3 (fr) Marqueurs biologiques de cancer de l'ovaire

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 08777023

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 08777023

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: JP